Journal article
EE390 Optimizing the Use of Risk Factors to Guide the Cost-Effective Use of Palivizumab Prophylaxis Against Severe Respiratory Syncytial Virus Infection in Korean Infants Born 32–35 Weeks’ Gestational Age
Authors
Keary I; Kang JM; Paes B; Rodgers-Gray B; Fullarton J; Tarride JE; Yang HJ; Chang YS; Carbonell-Estrany X
Journal
Value in Health, Vol. 26, No. 12,
Publisher
Elsevier
Publication Date
December 1, 2023
DOI
10.1016/j.jval.2023.09.656
ISSN
1098-3015